+34.3%
CVS vs FBTC
+62.0%
-27.7%
-43.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | FBTC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.7% | -0.3% | -0.5% | -0.7% |
| 7D | -1.9% | +1.1% | -3.0% | -1.9% |
| 30D | -0.3% | +22.3% | -22.6% | -1.0% |
| 3M | -1.1% | +26.0% | -27.1% | -2.0% |
| 6M | +23.7% | +13.2% | +10.6% | +23.0% |
| YTD | +23.0% | -10.7% | +33.7% | +23.2% |
| 1Y | +37.2% | -30.0% | +67.1% | +39.2% |
| All | +34.3% | +62.0% | -27.7% | +16.5% |
Cumulative growth
Daily Returns
Daily percentage return beside FBTC.
Daily Out/Under-Performance
Portfolio return minus FBTC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FBTC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded FBTC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling